References
- Norrby SR, Nord CE, Finch R. Lack of development of new antimicrobial drugs: a potential serious threat to public health. Lancet Infect Dis 2005;5:115–19
- Walsh C. Where will new antibiotics come from? Nature Rev Microbiol 2003;1:65–70
- Shadab Md, Mushir Ali, Sanjula Baboota, et al. Preparation, characterization, in vivo biodistribution and pharmacokinetic studies of donepezil-loaded PLGA nanoparticles for brain targeting. Drug Dev Ind Pharm 2013. [Epub ahead of print]
- Vrignaud S, Anton N, Passirani C, et al. Aqueous core nanocapsules: a new solution for encapsulating doxorubicin hydrochloride. Drug Dev Ind Pharm 2013. [Epub ahead of print]
- Du S, Zhu L, Du B, et al. Pharmacokinetic evaluation and antitumor activity of 2-methoxyestradiol nanosuspension. Drug Dev Ind Pharm 2012;38:431–8
- Yordanov GG, Bedzhova ZA, Dushkin CD. Preparation and physicochemical characterization of novel chlorambucil-loaded nanoparticles of poly(butylcyanoacrylate). Colloid & Polymer Science 2010;288:893–9
- Turos E, Reddy GS, Greenhalgh K, et al. Penicillin-bound polyacrylate nanoparticles: restoring the activity of beta-lactam antibiotics against MRSA. Bioorg Med Chem Lett 2007;17:3468–72
- Zhou T-H, Su M, Shang B-C, et al. Nano-hydroxyapatite/β-tricalcium phosphate ceramics scaffolds loaded with cationic liposomal ceftazidime: preparation, release characteristics in vitro and inhibition to Staphylococcus aureus biofilms. Drug Dev Ind Pharm 2012;38:1298–304
- Nishino T, Nakazawa S. Bacteriological study on effects of beta-lactam group antibiotics in high concentrations. Antimicrob Agents Chemother 1976;9:1033–42
- Kim BG, Kang IJ. Evaluation of the effects of biodegradable nanoparticles on a vaccine delivery system using AFM, SEM, and TEM. Ultramicroscopy 2008;108:1168–73
- Nishimura S, Tsurumoto T, Yonekura A, et al. Antimicrobial susceptibility of Staphylococcus aureus and Staphylococcus epidermidis biofilms isolated from infected total hip arthroplasty cases. J Orthop Sci 2006;11:46–50
- MacKenzie FM, Greig P, Morrison D, et al. Identification and characterization of teicoplanin-intermediate Staphylococcus aureus blood culture isolates in NE Scotland. J Antimicrob Chemother 2002;50:689–97
- Behan N, Birkinshaw C, Clarke N. Poly n-butyl cyanoacrylate nanoparticles: a mechanistic study of polymerisation and particle formation. Biomaterials 2001;22:1335–44
- Fattal E, Youssef M, Couvreur P, Andremont A. Treatment of experimental salmonellosis in mice with ampicillin-bound nanoparticles. Antimicrob Agents Chemother 1989;33:1540–3
- Shirotake S, Tomita Y, Yoshizaki S, Okuda K. Preparation of cyanoacrylate nanoparticles using monosaccharides or disaccharides. Chem Pharm Bull 2008;56:137–8
- Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, 5th ed. 2000 NCCLS document M7-A5
- Abeylath SC, Turos E. Glycosylated polyacrylate nanoparticles by emulsion polymerization. Carbohydr Polym 2007;70:32–37
- Luft JH. Improvements in epoxy resin embedding methods. J Biophys Biochem Cytology 1961;9:409–14
- Leak LV. Fine structure of the mucilaginous sheath of Anabaena sp. J Ultrastructure Res 1967;21:61–74
- Fattal E, Barratt G. Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA. Br Pharmacol Soc 2009;157:179–94
- Ozcan I, Segura-Sánchez F, Bouchemal K, et al. Pegylation of poly(γ-benzyl-L-glutamate) nanoparticles is efficient for avoiding mononuclear phagocyte system capture in rats. Int J Nanomed 2010;5:1103–11
- Yamamoto H, Tahara K, Kawashima Y. Nanomedical system for nucleic acid drugs created with the biodegradable nanoparticle platform. J Microencapsul 2012;29:54–62
- Ma Y, Zhao X, Li J, Shen Q. The comparison of different daidzein-PLGA nanoparticles in increasing its oral bioavailability. Int J Nanomed 2012;7:559–70
- Chen W, Hu S. Suitable carriers for encapsulation and distribution of endostar: comparison of endostar-loaded particulate carriers. Int J Nanomedicine 2011;6:1535–41
- Scherer D, Robinson JR, Kreuter J. Influence of enzymes on the stability of polybutylcyanoacrylate nanoparticles. Int J Pharmacol 1994;101:165–8
- He W, Jiang X, Zhang ZR. Preparation and evaluation of poly-butylcyanoacrylate nanoparticles for oral delivery of thymopentin. J Pharm Sci 2008;97:2250–9